- Home
- SIEB vs KPTI Comparison
SIEB vs KPTI Comparison
Compare SIEB & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIEB | KPTI |
|---|---|---|
| Founded | 1886 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 172.6M |
| IPO Year | 1996 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SIEB | KPTI |
|---|---|---|
| Price | $1.85 | $8.49 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $15.40 |
| AVG Volume (30 Days) | 37.2K | ★ 803.4K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.14 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | $83,901,000.00 | ★ $146,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $46.62 |
| P/E Ratio | $13.29 | ★ N/A |
| Revenue Growth | ★ 17.32 | 0.57 |
| 52 Week Low | $1.82 | $3.51 |
| 52 Week High | $5.53 | $10.99 |
Technical Indicators
Market Signals| Indicator | SIEB | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 15.73 | 49.58 |
| Support Level | N/A | $5.60 |
| Resistance Level | $3.26 | $8.95 |
| Average True Range (ATR) | 0.12 | 0.70 |
| MACD | -0.01 | -0.17 |
| Stochastic Oscillator | 9.38 | 9.31 |
Price Performance
Historical ComparisonAbout SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).